Clinical Trial Update: An Effective and Compliance Regimen of Paclitaxel Plus Cisplatin to Treat Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of paclitaxel plus cisplatin for metastatic breast cancer is described. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Breast Neoplasms | Phase 2 | Status: UNKNOWN